HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 213 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q1 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $489,421 | -66.8% | 14,935 | -64.4% | 0.00% | – |
| Q2 2023 | $1,475,658 | +30.4% | 41,934 | +20.9% | 0.00% | – |
| Q1 2023 | $1,132,041 | -17.3% | 34,672 | +39.6% | 0.00% | – |
| Q4 2022 | $1,368,739 | +197.6% | 24,841 | +139.0% | 0.00% | – |
| Q3 2022 | $460,000 | -35.8% | 10,395 | -29.3% | 0.00% | – |
| Q2 2022 | $717,000 | -13.3% | 14,702 | -13.5% | 0.00% | – |
| Q1 2022 | $827,000 | -20.8% | 16,991 | -30.6% | 0.00% | – |
| Q4 2021 | $1,044,000 | -66.8% | 24,469 | -70.2% | 0.00% | -100.0% |
| Q3 2021 | $3,148,000 | +1040.6% | 82,144 | +741.6% | 0.00% | – |
| Q2 2021 | $276,000 | +21.1% | 9,761 | +41.4% | 0.00% | – |
| Q1 2021 | $228,000 | -81.0% | 6,904 | -79.2% | 0.00% | – |
| Q4 2020 | $1,201,000 | +3432.4% | 33,216 | +3221.6% | 0.00% | – |
| Q3 2020 | $34,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Valor Management LLC | 11,218,033 | $366,268,777 | 96.46% |
| venBio Partners LLC | 1,035,396 | $33,805,679 | 18.74% |
| Nan Fung Group Holdings Ltd | 368,665 | $12,036,912 | 8.19% |
| Vivo Capital, LLC | 2,606,247 | $85,093,965 | 5.90% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 570,500 | $18,621,120 | 5.20% |
| ASHFORD CAPITAL MANAGEMENT INC | 445,418 | $14,542,898 | 2.18% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 678,715 | $22,160,045 | 2.07% |
| TANG CAPITAL MANAGEMENT LLC | 321,200 | $10,487,180 | 1.56% |
| AlphaCentric Advisors LLC | 67,500 | $2,203,875 | 1.52% |
| Paradiem, LLC | 66,995 | $2,187,387 | 0.68% |